These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 3414726)

  • 21. The presence of cachectin/tumor necrosis factor in human disease states.
    Beutler B
    Am J Med; 1988 Sep; 85(3):287-8. PubMed ID: 3414725
    [No Abstract]   [Full Text] [Related]  

  • 22. Cachectin/tumor necrosis factor and other cytokines in infectious disease.
    Tracey KJ; Cerami A
    Curr Opin Immunol; 1989 Feb; 1(3):454-61. PubMed ID: 2679705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of in-vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumour necrosis factor.
    Michihiko S; Yamamoto N; Shinozaki F; Shimada K; Soma G; Kobayashi N
    Lancet; 1989 May; 1(8648):1206-7. PubMed ID: 2566769
    [No Abstract]   [Full Text] [Related]  

  • 24. Human immunodeficiency virus infection in hemophiliac patients. A three-year prospective evaluation.
    Daul CB; deShazo RD; Andes WA
    Am J Med; 1988 May; 84(5):801-9. PubMed ID: 3163229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma fibronectin values in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
    Ogden DM; Fischer HE; Liu FJ; Rios A; Lichtiger B
    Am J Clin Pathol; 1988 Sep; 90(3):293-6. PubMed ID: 3414601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumors secreting human TNF/cachectin induce cachexia in mice.
    Oliff A; Defeo-Jones D; Boyer M; Martinez D; Kiefer D; Vuocolo G; Wolfe A; Socher SH
    Cell; 1987 Aug; 50(4):555-63. PubMed ID: 3607879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of pentoxifylline therapy for patients with AIDS-related wasting: pilot study.
    Landman D; Sarai A; Sathe SS
    Clin Infect Dis; 1994 Jan; 18(1):97-9. PubMed ID: 8054441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells.
    Ogawa H; Nielsen S; Kawakami M
    Biochim Biophys Acta; 1989 Jun; 1003(2):131-5. PubMed ID: 2786429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological responses to cachectin.
    Tracey KJ; Lowry SF; Cerami A
    Ciba Found Symp; 1987; 131():88-108. PubMed ID: 2836140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum prolactin concentrations in patients with the acquired immunodeficiency syndrome.
    Chernow B; Schooley RT; Dracup K; Napolitano LM; Stanford GG; Klibanski A
    Crit Care Med; 1990 Apr; 18(4):440-1. PubMed ID: 2318055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha.
    Agostini C; Zambello R; Trentin L; Garbisa S; Di Celle PF; Bulian P; Onisto M; Poletti V; Spiga L; Raise E
    Am Rev Respir Dis; 1991 Jul; 144(1):195-201. PubMed ID: 2064129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary intake in patients with acquired immunodeficiency syndrome (AIDS), patients with AIDS-related complex, and serologically positive human immunodeficiency virus patients: correlations with nutritional status.
    Dworkin BM; Wormser GP; Axelrod F; Pierre N; Schwarz E; Schwartz E; Seaton T
    JPEN J Parenter Enteral Nutr; 1990; 14(6):605-9. PubMed ID: 2273533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma fibronectin concentrations in patients with human immunodeficiency virus infection.
    Torre D; Issi M; Sampietro C; Fiori GP; Chelazzi G; Ferraro G
    J Clin Pathol; 1990 Jul; 43(7):560-2. PubMed ID: 2380404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations.
    Reddy MM; Grieco MH
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):115-20. PubMed ID: 2966633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulation of HIV antigen in blood according to stage of infection, risk group, age and geographic origin.
    Goudsmit J; Paul DA
    Epidemiol Infect; 1987 Dec; 99(3):701-10. PubMed ID: 3428375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.
    Noronha IL; Daniel V; Schimpf K; Opelz G
    Clin Exp Immunol; 1992 Feb; 87(2):287-92. PubMed ID: 1735193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cachectin/TNF kills or inhibits the differentiation of 3T3-L1 cells according to developmental stage.
    Kawakami M; Watanabe N; Ogawa H; Kato A; Sando H; Yamada N; Murase T; Takaku F; Shibata S; Oda T
    J Cell Physiol; 1989 Jan; 138(1):1-7. PubMed ID: 2783422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of cachectin/tumor necrosis factor in AIDS.
    Tracey KJ; Cerami A
    Cancer Cells; 1989 Oct; 1(2):62-3. PubMed ID: 2641271
    [No Abstract]   [Full Text] [Related]  

  • 39. Cachectin activity in the serum of cachectic, tumor-bearing rats.
    Stovroff MC; Fraker DL; Norton JA
    Arch Surg; 1989 Jan; 124(1):94-9. PubMed ID: 2910253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
    Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M
    J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.